ROCK inhibitors have successfully improved cyst formation in ADPKD, suggesting that the cytoskeletal-associated RhoA/ROCK pathway may be a major factor in cyst initiation [16]. Here, RHOA is linked to autosomal dominant polycystic kidney disease.